1.
Akdeniz O, Akduman D, Haksever M, Ozkarakas H, Muezzinoglu B (2013). Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin. Asian Pac J Cancer Prev, 14, 5301-10.
2.
Cao XL, Xu RJ, Zheng YY (2011). Expression of type IV collagen, metalloproteinase-2, metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in laryngeal squamous cell carcinomas. Asian Pac J Cancer Prev, 12, 3245-9.
3.
Christopoulos TA, Papageorgakopoulou N, Theocharis DA, et al (2006). Hyaluronidase and CD44 hyaluronan receptor expression in squamous cell laryngeal carcinoma. Biochim Biophys Acta, 1760, 1039-45.
4.
Christopoulos TA, Papageorgakopoulou N, Theocharis DA, et al (2004). Diagnostic and classification value of metalloproteinases in squamous human laryngeal carcinoma. Int J Oncol, 25, 481-5.
5.
Colovic Z, Pesutic-Pisac V, Poljak NK, et al (2013). Expression of matrix metalloproteinase-9 in patients with squamous cell carcinoma of the Larynx. Coll Antropol, 37, 151-5.
6.
Ferlay J, Parkin DM, Steliarova-Foucher E (2010). Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer, 46, 765-81
7.
Gou XX, Jin F, Chen HX (2010). Expressions of CD147, MMP-2 and MMP-9 in laryngeal carcinoma and clinical significance. Zhonghua Yi Xue Za Zhi, 90, 1264-7.
8.
Knapinska A, Fields GB (2012). Chemical biology for understanding matrix metalloproteinase function. Chembiochem, 13, 2002-20.
9.
Kondakova IV, Klisho EV, savenkova OV (2008). Matrix metalloproteinase 2 and 9 as the factor of head and neck tumor metastasis. Biomed Khim, 54, 555-60.
10.
Krecicki T, Zalesska-Krecicka M, Jelen M, Szkudlarek T, Horobiowska M (2001). Expression of type IV collagen and matrix metalloproteinase-2 (type IV collagenase) in relation to nodal status in laryngeal cancer. Clin Otolaryngol Allied Sci, 26, 469-72
11.
Lotfi A, Mohammadi G, Tavassoli A, et al (2015). Serum levels of MMP9 and MMP2 in patients with oral squamous cell carcinoma. Asian Pac J Cancer Prev, 16, 1327-30.
12.
Lin Y, Zhang J, Liu S, et al (2012) [Significance expression and relationships with endothelin-1, matrix metalloproteinase-9 in the laryngeal carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 26, 245-7.
13.
Liotta LA (1986). Tumor invasion and metastases - role of the extracellular matrix: rhoads memorial award lecture. Cancer Res, 46, 1-7.
14.
Mallis A, Teymoortash A, Mastronikolis NS (2012). MMP-2 expression in 102 patients with glottic laryngeal cancer. Eur Arch Otorhinolaryngol, 269, 639-42.
15.
Marioni G, Marchese-Ragona R, Cartei G, Marchese F, Staffieri A (2006). Current opinion in diagnosis and treatment of laryngeal carcinoma. Cancer Treat Rev, 32, 504-15.
16.
Pereira AC, Dias do Carmo E, Dias da Silva MA, Blumer Rosa LE (2012). Matrix metalloproteinase gene polymorphisms and oral cancer. J Clin Exp Dent, 4, 297-301.
17.
Peschos D, Damala C, Stefanou D, et al (2006). Expression of matrix metalloproteinase-9 (gelatinase B) in benign, premalignant and malignant laryngeal lesions. Histol Histopathol, 21, 603-8.
18.
Ramroth H, Schoeps A, Rudolph E, et al (2011). Factors predicting survival after diagnosis of laryngeal cancer. Oral Oncol, 47, 1154-8.
19.
Rosenthal EL, Matrisian LM (2006). Matrix metalloproteinases in head and neck cancers. Head Neck, 10, 639-648.
20.
Shuman Moss LA, Jensen-Taubman S, Stetler-Stevenson WG (2012) Matrix metalloproteinases: changing roles in tumor progression and metastasis. Am J Pathol, 181, 1895-9.
21.
Sun C, Xin D, Wang Y (2007). The expression of MMP-2, E-cadherin in supraglottic carcinoma and their relationship with cervical lymph node metastasis. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 21, 834-7.
22.
Tang X, Shen X, Qian X, Gao X (2013). [Expressions of HMGB1, MMP-2 and MMP-9 and prognostic alue in human laryngeal carcinoma]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, 27, 181-7.
23.
Uloza V, Liutkevicius V, Pangonyte D, Saferis V, Lesauskaite V (2011). Expression of matrix metalloproteinases (MMP- 2 and MMP-9) in recurrent respiratory papillomas and laryngeal carcinoma: clinical and morphological parallels. Eur Arch Otorhinolaryngol, 268, 871-8.
24.
Wang X, Shan Y, Wang J, Luo S (2006). [Expression and clinical significance of matrix metalloproteinase-2 in laryngeal squamous cell carcinoma]. Lin Chuang Er Bi Yan Hou Ke Za Zhi, 20, 1109-10.
25.
Wittekindt C, Jovanovic N, Guntinas-Lichius O (2011). Expression of matrix metalloproteinase-9 (MMP-9) and blood vessel density in laryngeal squamous cell carcinomas. Acta Otolaryngol, 131, 101-6.
26.
Yu TY, Pang JH, Wu KP, et al (2013). Aging is associated with increased activities of matrix metalloproteinase-2 and -9 in tenocytes. BMC Musculoskelet Disord, 14, 2.